Clinical Trials Browser

Phase 1 × Completed × fosaprepitant × Clear all

NCT04636632 2022-11-07

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase 1 Completed

Nasopharyngeal Carcinoma